Celyad Oncology SA
XBRU:CYAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
|
Piramal Enterprises Ltd
BSE:500302
|
IN |
|
E
|
Earth Tech Environment PCL
SET:ETC
|
TH |
|
F
|
Frasers Property Thailand Industrial Freehold & Leasehold REIT
SET:FTREIT
|
TH |
|
L
|
Landmark Land Co Inc
OTC:LLND
|
US |
|
I
|
Indutrade AB
SWB:I1M
|
SE |
|
I
|
Iluka Resources Ltd
OTC:ILKAF
|
AU |
|
Sonoro Energy Ltd
F:FDZN
|
CA |
|
E
|
Energy Development Company Ltd
NSE:ENERGYDEV
|
IN |
|
D
|
Defiance Silver Corp
SWB:D4E
|
CA |
|
Damora Therapeutics Inc
NASDAQ:DMRA
|
US |
Shareholder Yield
Current shareholder yield for CYAD is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CYAD Price
Celyad Oncology SA
| Average Annual Return | -16.18% |
| Standard Deviation of Annual Returns | 70% |
| Max Drawdown | -96% |
| Market Capitalization | 9.2m EUR |
| Shares Outstanding | 47 260 000 |
| Percentage of Shares Shorted |
N/A
|
